The government has made it mandatory for its eligible citizens to take the shot. As of Saturday, 1.47 million people have received their first dose of the Sinovac Biotech Ltd. vaccine, while over 900,000 have taken their second.(Bloomberg)
The government has made it mandatory for its eligible citizens to take the shot. As of Saturday, 1.47 million people have received their first dose of the Sinovac Biotech Ltd. vaccine, while over 900,000 have taken their second.(Bloomberg)

Grab Drive-Thru service to boost Indonesia's mass-inoculation drive

The program, which started Sunday on the resort island of Bali, is the first to be done in Southeast Asia, Grab Indonesia President Ridzki Kramadibrata said in a virtual news briefing.
Bloomberg |
PUBLISHED ON FEB 28, 2021 01:27 PM IST

Southeast Asia’s ride-hailing giant Grab Holdings Inc. is setting up drive-thru vaccination services in Indonesia in collaboration with the government to help the nation inoculate more than 180 million people against Covid-19.

The program, which started Sunday on the resort island of Bali, is the first to be done in Southeast Asia, Grab Indonesia President Ridzki Kramadibrata said in a virtual news briefing. About 3,000 people working in the tourism industry were present at the Bali centre to receive their first shot. Details on other locations weren’t immediately available.

Indonesia is aggressively rolling out a mass-inoculation drive as it struggles to contain the largest coronavirus outbreak in Southeast Asia. It plans to vaccinate 70 million people by August, roughly a third of the total target of 181.5 million for the public campaign.

Indonesia Allows Private Vaccine Program to Quicken Rollout

The government has made it mandatory for its eligible citizens to take the shot. As of Saturday, 1.47 million people have received their first dose of the Sinovac Biotech Ltd. vaccine, while over 900,000 have taken their second. Around 1.3 million people in the country have been infected and more than 35,000 died from the virus.


SHARE THIS ARTICLE ON
Close
SHARE
Story Saved
OPEN APP